Long-term methylphenidate use for children and adolescents with attention deficit hyperactivity disorder and risk for depression, conduct disorder, and psychotic disorder: a nationwide longitudinal cohort study in South Korea

• Үндсэн зохиолчид: Jimyung Park (Зохиогч), Dong Yun Lee (Зохиогч), Chungsoo Kim (Зохиогч), Yo Han Lee (Зохиогч), Su-Jin Yang (Зохиогч), Sangha Lee (Зохиогч), Seong-Ju Kim (Зохиогч), Jeewon Lee (Зохиогч), Rae Woong Park (Зохиогч), Yunmi Shin (Зохиогч)
• Формат: Ном
• Хэвлэсэн: BMC, 2022-10-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract Background Methylphenidate (MPH) is the most frequently prescribed medication for the treatment of attention deficit hyperactivity disorder (ADHD). However, the safety of its long-term use remain unclear. In particular, real-world evidence of long-term MPH treatment regarding the risk of de...